Bionovo, Inc. to Announce Fourth Quarter and Year-End Financial Results on Thursday, March 12, 2009
Company to Review Plans for 2009
EMERYVILLE, Calif., March 6 /PRNewswire-FirstCall/ -- Bionovo, Inc.
(Nasdaq: BNVI) announced today that it will release financial results for the
fourth quarter and the year ended December 31, 2008 on Thursday, March 12,
2009. The Company will conduct a conference call and web cast to review the
financial results and the Company's plans for 2009 on Thursday, March 12, 2009
at 4:30 p.m. ET.
Interested parties can access the call by dialing (877) 356-5706 or (706)
643-0580, or can listen via a live Internet web cast, which can be found at
http://bionovo.com/investors/events. A replay of the call is available via web
cast at http://bionovo.com/investors/events for 30 days or by playback at
(800) 642-1687 or (706) 645-9291, access code 88102099, through March 15,
2009.
About Bionovo, Inc.
Bionovo, Inc. is a pharmaceutical company focused on the discovery and
development of safe and effective treatments for women's health and cancer,
markets with significant unmet needs and billions in potential annual revenue.
The company applies its expertise in the biology of menopause and cancer to
design new drugs derived from botanical sources which have novel mechanisms of
action. Based on the results of early and mid-stage clinical trials, Bionovo
believes they have discovered new classes of drug candidates within their rich
pipeline with the potential to be leaders in their markets. Bionovo is
headquartered in Emeryville, California and is traded on the NASDAQ Capital
Market under the symbol, "BNVI". For more information about Bionovo and its
programs, visit: http://www.bionovo.com. BNVI-F
Contacts:
Bionovo, Inc. Lytham Partners, LLC
Claire Fong Joe Diaz, Robert Blum, Joe Dorame
Tom Chesterman (602) 889-9700
(510) 601-2000 BNVI@lythampartners.com
investor@bionovo.com
View printer-friendly version